Ensayos clínicos

Inclusion Criteria:

All subjects eligible for this study will meet the following inclusion criteria:

• Age between 18 to 80 years
• Estimated GFR ≥15 mL/min/1.73m²
• Ability to provide consent and complete all aspects of the study

Exclusion Criteria: 

• Subjects will be excluded from participation if they have any of the following exclusion criteria:
• Diabetes Mellitus
• Pregnant
• Evidence of hepatitis B or C, or HIV infection (this will be assessed through the EMR)
• Solid organ transplantation
• Nephrotic syndrome
• Immunosuppression therapy
• Active glomerulonephritis
• Autosomal dominant or recessive polycystic kidney disease
• Known RVD
• Active malignancy to minimize interference of underlying conditions or treatments on MSC functionality.
• Subjects on therapeutic doses of anticoagulants [Rivaroxaban (Xarleto); Apixaban (Eliquis); Dabigatran (Pradaxa, Prazaxa)].
• History of substance abuse (including alcohol) within the past 2 years
• Active substance abuse (>3 alcoholic beverages/day or>21 per week)
• Body weight >150 kg or BMI >50
• Uncontrolled psychiatric disorder